Evidence map›Paper›PMID 28336879›Full record

ArticleNanomaterials (Basel, Switzerland)2017

In Vitro and In Vivo Evaluation of a Three-Dimensional Porous Multi-Walled Carbon Nanotube Scaffold for Bone Regeneration.

Manabu Tanaka, Yoshinori Sato, Mei Zhang, Hisao Haniu, Masanori Okamoto, Kaoru Aoki, Takashi Takizawa, Kazushige Yoshida, Atsushi Sobajima, Takayuki Kamanaka and 2 more

Abstract read
In one paragraph

Article in Nanomaterials (Basel, Switzerland), 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Future Prospects for Clinical Applications of Nanocarbons Focusing on Carbon Nanotubes.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2022
    Article
  5. Review
  6. Article
  7. Review
  8. Review
  9. Review
  10. Article
  11. Applications of Carbon Nanotubes in Bone Regenerative Medicine.Nanomaterials (Basel, Switzerland) · 2020
    Review
  12. Review
  13. Article
  14. Article
  15. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Manabu TanakaDepartment of Orthopaedic Surgery, School of Medicine, Shinshu University, Asahi 3-1-1, Matsumoto, Nagano 390-8621, Japan. m990054e@gmail.com.
Yoshinori SatoGraduate School of Environmental Studies, Tohoku University, Aoba 6-6-20, Aramaki, Aoba-ku, Sendai 980-8579, Japan. yoshinori.sato.b5@tohoku.ac.jp.
Mei ZhangHigh-Performance Materials Institute, Florida State University, 2005 Levy Avenue, Tallahassee, FL 32310, USA. mzhang3@fsu.edu.
Hisao HaniuDepartment of Orthopaedic Surgery, School of Medicine, Shinshu University, Asahi 3-1-1, Matsumoto, Nagano 390-8621, Japan. hhaniu@shinshu-u.ac.jp.
Masanori OkamotoDepartment of Orthopaedic Surgery, School of Medicine, Shinshu University, Asahi 3-1-1, Matsumoto, Nagano 390-8621, Japan. ryouyuma@shinshu-u.ac.jp.
Kaoru AokiDepartment of Orthopaedic Surgery, School of Medicine, Shinshu University, Asahi 3-1-1, Matsumoto, Nagano 390-8621, Japan. kin29men@shinshu-u.ac.jp.
Takashi TakizawaDepartment of Orthopaedic Surgery, School of Medicine, Shinshu University, Asahi 3-1-1, Matsumoto, Nagano 390-8621, Japan. takashitak@shinshu-u.ac.jp.
Kazushige YoshidaDepartment of Orthopaedic Surgery, School of Medicine, Shinshu University, Asahi 3-1-1, Matsumoto, Nagano 390-8621, Japan. gooddays83@yahoo.co.jp.
Atsushi SobajimaDepartment of Orthopaedic Surgery, School of Medicine, Shinshu University, Asahi 3-1-1, Matsumoto, Nagano 390-8621, Japan. soba@shinshu-u.ac.jp.
Takayuki KamanakaDepartment of Orthopaedic Surgery, School of Medicine, Shinshu University, Asahi 3-1-1, Matsumoto, Nagano 390-8621, Japan. kam17@hotmail.co.jp.
Hiroyuki KatoDepartment of Orthopaedic Surgery, School of Medicine, Shinshu University, Asahi 3-1-1, Matsumoto, Nagano 390-8621, Japan. hirokato@shinshu-u.ac.jp.
Naoto SaitoDepartment of Orthopaedic Surgery, School of Medicine, Shinshu University, Asahi 3-1-1, Matsumoto, Nagano 390-8621, Japan. saitoko@shinshu-u.ac.jp.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Carbon nanotubes (CNTs) have attracted a great deal of attention for the biological and medical science fields because of their characteristic physical and biological properties. In this study, we investigated the capacity of the 3D porous CNT scaffold (CNT porous block; CNTp) for bone regenerative medicine. Surface observations using a scanning electron microscope (SEM), crystal depositions on the surface of CNTps immersed in simulated body fluid (SBF), and evaluations of protein adsorption and controlled releasing were conducted to assess physical properties. The cell proliferation and cell morphology were observed using SEM and fluorescent microscopy. CNTps were implanted into critical-size mouse calvarial defects and evaluated for their osteoconductive ability and in vivo controlled release of recombinant human BMP-2 (rhBMP-2). Interconnected porous HA ceramics (IP-CHAs) were used for comparison. CNTps have multiporous structures with interporous connections with networks of multiwalled CNTs. Crystals containing calcium and phosphate were deposited in CNTps and on the surface of the CNT networks by immersing CNTps in SBF. CNTps adsorbed more significantly and released protein more gradually than IP-CHAs. Preosteoblasts seeded onto CNTps filled pores with stretched actin filaments and filopodia. Compared with IP-CHAs, CNTps showed significantly higher cell proliferation, better osteoconduction, and more bone generation with rhBMP-2. In this study, CNTps demonstrated good osteoconductive ability, cell attachment and proliferation capacity, and growth factor retaining ability. CNTps have the potential not only as artificial bones for the treatment of bone defects, but also as scaffolds for regenerative medicine using tissue engineering approaches.

Indexed as

bone regenerationcarbon nanotubetissue engineering

Identifiers

PMID28336879
PMCPMC5333031

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.